This article is more than 5 years old. Information may no longer be current.
Top lupus research from ACR 2016
Click Here to Manage Email Alerts
Researchers presented data and clinical updates on lupus at the 2016 American College of Rheumatology Annual Meeting. Live coverage from Washington featured news from the conference, onsite video interviews with leading experts and research implications on patient care and practice.
Healio Internal Medicine presents the top four lupus stories from ACR 2016.
Homocysteine treatment improved urine protein/creatinine ratio in patients with lupus
WASHINGTON — Treatment of high homocysteine levels improved the urine protein/creatinine ratio in patients with lupus, according to data presented at the American College of Rheumatology Annual Meeting. Read More.
Short-term renal parameters predicted long-term lupus outcomes
WASHINGTON — A hazard index tool based on short-term renal parameters predicted long-term outcomes in patients with lupus nephritis, according to data presented at the American College of Rheumatology Annual Meeting. Read More.
Biomarker algorithm may predict lupus treatment response
WASHINGTON — The renal activity in lupus urinary biomarker algorithm can predict treatment response, according to data presented at the American College of Rheumatology Annual Meeting. Read More.
Poverty worsens lupus effects
WASHINGTON — Patients with lupus who were poor for more years showed more disease damage than patients who are poor for fewer years or were never poor, according to data presented at the American College of Rheumatology Annual Meeting, here. Read More.